> ## Site index
> Full index of Peptides.build at https://peptides.build/llms.txt. Use it to discover every page.

# What Is Compounded Tirzepatide? Is It Safe?

Compounded tirzepatide explained: the dual GIP and GLP-1 agonist, how it differs from Zepbound and Mounjaro, what the trials covered, safety and FDA status.

URL: https://peptides.build/learn/what-is-compounded-tirzepatide/

Guide · Weight Management

# What is compounded tirzepatide?

Published October 12, 2026 · Educational, not medical advice

## Short answer

Compounded tirzepatide is tirzepatide, a dual GIP and GLP-1 receptor agonist, prepared by a licensed 503A pharmacy for one patient from a prescription. Tirzepatide itself is FDA-approved as the branded drugs Zepbound and Mounjaro, and its large randomized trials were run on those products. The compounded medication is not FDA-approved. It is a once-weekly injection prescribed only after a licensed provider reviews your history.

-   [What is tirzepatide, and how is it different from other GLP-1s?](#what)
-   [Is compounded tirzepatide the same as Zepbound or Mounjaro?](#brands)
-   [What has tirzepatide been studied for?](#research)
-   [Is compounded tirzepatide safe?](#safe)
-   [How is compounded tirzepatide prescribed?](#prescribed)
-   [FAQ](#faq)
-   [References](#references)

<table class="ln-facts pb-body"><caption class="pc-sr">Compounded tirzepatide quick facts</caption><tbody><tr><th scope="row">Type</th><td>Dual agonist of the GIP and GLP-1 receptors, the two main incretin hormones</td></tr><tr><th scope="row">Also known as</th><td>Tirzepatide injection, compounded tirz</td></tr><tr><th scope="row">Evidence to date</th><td>Large randomized trials of the branded products in obesity and type 2 diabetes, including head-to-head trials against semaglutide; none of compounded versions</td></tr><tr><th scope="row">Form in this catalog</th><td>Once-weekly subcutaneous injection, supplied already in solution with the concentration on the label</td></tr><tr><th scope="row">Regulatory status</th><td>Compounded tirzepatide is not FDA-approved; tirzepatide is FDA-approved as Zepbound and Mounjaro</td></tr><tr><th scope="row">Main cautions</th><td>Personal or family history of medullary thyroid carcinoma or MEN 2, pregnancy, history of pancreatitis</td></tr></tbody></table>

Evidence snapshot**What kind of research is cited for Compounded tirzepatide?**3 cited sources: 3 human clinical trials. Counts describe study type, not strength of result.

Sources cited for Compounded tirzepatide, by study type
| Study type | Sources |
| --- | --- |
| Human clinical trials | 3 |
| Other human studies | 0 |
| Animal and lab studies | 0 |
| Review articles | 0 |

## What is tirzepatide, and how is it different from other GLP-1s?

Tirzepatide is a synthetic peptide that acts on two hormone receptors at once: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Both are incretins, hormones the gut releases after eating that act on insulin release, appetite signaling and stomach emptying. Earlier medications in the class, semaglutide among them, act on GLP-1 alone.

Like semaglutide, tirzepatide is built to last about a week in the body, so it is given as a once-weekly injection. Compounded tirzepatide is the same active molecule prepared by a licensed 503A pharmacy for one named patient from that patient's prescription.

## Is compounded tirzepatide the same as Zepbound or Mounjaro?

Compounded tirzepatide contains the same active ingredient as Zepbound and Mounjaro, but it is a different product. Zepbound and Mounjaro are manufactured to an FDA-approved specification and approved for specific indications. A compounded vial is prepared by a pharmacy for an individual prescription, carries that pharmacy's label and concentration, and is not approved for any indication.

Branded tirzepatide and compounded tirzepatide
|  | Branded (Zepbound, Mounjaro) | Compounded |
| --- | --- | --- |
| Active ingredient | Tirzepatide | Tirzepatide |
| Made by | The manufacturer, to an FDA-approved specification | A licensed 503A pharmacy, for one patient's prescription |
| FDA status | Approved for specific indications | Not FDA-approved |
| Delivery | Pre-filled pen or vial from the manufacturer | Vial and syringe, already in solution |
| Label | Manufacturer's label | Pharmacy label with your name and the concentration |

Prescribed, pre-mixed

## Get Compounded Tirzepatide prescribed, pre-mixed

 US-supervised · all 50 states

[Compounded Tirzepatide](https://peptides.build/protocols/compound-tirzepatide/)FDA-approved brand exists

**$118**/mo*$1,416 billed every 12 months*

Pay over time at checkout![Klarna](/media/payments/klarna.png)![Afterpay](/media/payments/afterpay.png)![Affirm](/media/payments/affirm.png)

Prescription required. Your provider decides if it is appropriate. Compounded medications are not FDA-approved.

 US-supervised · all 50 states

[Compounded Semaglutide](https://peptides.build/protocols/compound-semaglutide/)FDA-approved brand exists

**$68**/mo*$816 billed every 12 months*

Pay over time at checkout![Klarna](/media/payments/klarna.png)![Afterpay](/media/payments/afterpay.png)![Affirm](/media/payments/affirm.png)

Prescription required. Your provider decides if it is appropriate. Compounded medications are not FDA-approved.

## What has tirzepatide been studied for?

Tirzepatide's trial program was run on the branded product. The SURMOUNT-1 trial, published in 2022, compared once-weekly tirzepatide with placebo over 72 weeks in adults with obesity, or overweight with a weight-related condition, who did not have diabetes. The SURPASS-2 trial compared tirzepatide with semaglutide in adults with type 2 diabetes, and the SURMOUNT-5 trial, published in 2025, compared the two head to head in adults with obesity without diabetes.

These trials describe tirzepatide as a manufactured drug. None of them studied a compounded preparation, and the averages they report do not predict what any one person will see.

## Is compounded tirzepatide safe?

Compounded tirzepatide carries the same known cautions as the molecule. The branded products carry a boxed warning about thyroid C-cell tumors seen in rodents, so tirzepatide is not prescribed to people with a personal or family history of medullary thyroid carcinoma or with multiple endocrine neoplasia syndrome type 2. The labeling also lists pancreatitis, gallbladder problems and stomach side effects, which is why the strength is raised step by step over the first weeks.

The compounding questions are about the vial: who made it, under what standards and whether the label is accurate. A licensed 503A pharmacy compounds for a named patient under its state board and sterile compounding standards, with a pharmacist accountable for the batch. Tirzepatide sold online as research use only has none of that: no prescriber, no pharmacy and no screening.

-   Ask who prescribed it, by name, and which pharmacy's name is on the label.
-   Check that the concentration is printed on the vial in mg/mL.
-   Tell your provider about thyroid history, pancreatitis, gallbladder problems, oral contraceptives and any diabetes medication before the first prescription.

## How is compounded tirzepatide prescribed?

Compounded tirzepatide is prescribed through Peptides.build after an online medical intake. A licensed US provider reviews your history and prescribes it only if appropriate; a licensed 503A pharmacy compounds it and ships it cold-chain, already in solution with the concentration on the label.

The provider sets the starting strength, the pace of each step up and the schedule, and adjusts them at check-ins. Those figures are not published on this site. The number of units to draw comes from the provider's directions and the label concentration.

Prescription, not research grade

## Prescribed Compounded tirzepatide vs research peptides: what is different?

Prescribed Compounded tirzepatide is not a research chemical. It is a prescription medication: a licensed US provider reviews your intake first, and a licensed 503A pharmacy compounds it for you by name. Vials sold online as “research use only” skip both steps. What you pay for here is that review, a pharmacy you can name, and a label that says what is in the vial.

A research seller’s certificate of analysis is a document the seller controls: it chooses the lab and the sample, and a PDF can be reused, edited or re-dated. No regulator checks it.

Prescribed Compounded tirzepatide compared with research-use-only peptides
| Point | Prescribed through Peptides.build | Research use only |
| --- | --- | --- |
| Access | Online intake reviewed by a licensed US provider; prescribed only when appropriate. | No prescription and no clinical review of whether it suits you. |
| How it's labeled | A prescription medication compounded for you by name. | Commonly sold labeled “research use only, not for human consumption.” |
| Who prepares it | A licensed 503A US compounding pharmacy under state and federal oversight. | Unregulated suppliers, often with no verifiable chain of custody. |
| Testing | Third-party tested. | Certificates of analysis are self-reported when provided at all. |
| Purity and identity | Prepared to a prescription for a specific patient. | Purity, strength, and even identity are unverified by any independent party. |

This compares two care models, not two products. Compounded medications are not FDA-approved, and we do not claim otherwise. What a prescription adds is a licensed provider deciding whether a protocol is appropriate for you and a licensed pharmacy preparing it. [Read the full guide to research vs prescription peptides](https://peptides.build/learn/research-peptides-vs-prescription-peptides/).

Common questions

## Compounded tirzepatide FAQ

### Is compounded tirzepatide FDA-approved?

No. Tirzepatide is FDA-approved as the branded drugs Zepbound and Mounjaro. Compounded tirzepatide is prepared by a licensed 503A pharmacy for an individual patient and is not FDA-approved.

### Is compounded tirzepatide the same as Zepbound?

Same active ingredient, different product. Zepbound is manufactured to an FDA-approved specification; compounded tirzepatide is a pharmacy preparation for one patient's prescription and is not FDA-approved.

### Is compounded tirzepatide safe?

It carries the molecule's known cautions, including a boxed warning about thyroid C-cell tumors in rodents and warnings about pancreatitis and gallbladder problems, so a provider screens for them first. A licensed 503A pharmacy prepares it under sterile compounding standards, but the compounded product itself has not been reviewed by the FDA.

### What does dual agonist mean?

It means tirzepatide activates two receptors, GIP and GLP-1, rather than one. Semaglutide activates GLP-1 only.

### How often is tirzepatide injected?

Once a week, as a subcutaneous injection. The provider raises the strength in steps over the first weeks and sets the schedule.

Prescribed, not mixed at home

## Compounded Tirzepatide through Peptides.build

A licensed US provider reviews a short online intake and decides whether a protocol is appropriate. A US 503A pharmacy prepares it already reconstituted, labels the concentration and ships it cold-chain. Dosing is set by the provider and is not published on this site.

-   [Compounded Tirzepatide protocol: pricing, who it is for, FAQ](https://peptides.build/protocols/compound-tirzepatide/)
-   [Compounded Semaglutide protocol: pricing, who it is for, FAQ](https://peptides.build/protocols/compound-semaglutide/)
-   [All weight management protocols compared](https://peptides.build/protocols/weight-management/)
-   [What is compounded semaglutide?](https://peptides.build/learn/what-is-compounded-semaglutide/)
-   [Semaglutide vs tirzepatide: what is the difference?](https://peptides.build/learn/semaglutide-vs-tirzepatide/)
-   [Are research peptides safe? Research use only vs. prescription peptides](https://peptides.build/learn/research-peptides-vs-prescription-peptides/)

Sources

## References

1.  Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). *New England Journal of Medicine*, 2022. [doi:10.1056/NEJMoa2206038](https://doi.org/10.1056/NEJMoa2206038)Study type: Randomized controlled trial
2.  Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). *New England Journal of Medicine*, 2021. [doi:10.1056/NEJMoa2107519](https://doi.org/10.1056/NEJMoa2107519)Study type: Randomized controlled trial (head to head, type 2 diabetes)
3.  Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). *New England Journal of Medicine*, 2025. [doi:10.1056/NEJMoa2416394](https://doi.org/10.1056/NEJMoa2416394)Study type: Randomized controlled trial (head to head, obesity)

Citations are listed with their study type so the evidence can be weighed. Review articles summarize other studies; animal and in vitro findings do not describe outcomes in people.

This article is educational and is not medical advice. Compounded tirzepatide is not FDA-approved, and compounded medications are not FDA-approved. No results are implied or guaranteed. Talk to a licensed provider about your own history before starting any protocol.